Editor,
During the coronavirus disease 2019 (COVID‐19) pandemic, frontline healthcare workers (HCW) are working tirelessly for long hours to provide patient care. Although COVID is not dermatotropic, prolonged contact with personal protective equipment (PPE, i.e. goggles, face‐shield/visor, N 95 respirator, double‐layered gloves, coverall/gowns, head cover and shoe cover) may cause various dermatoses. Several dermatoses have been reported due to PPE, such as pressure injury, contact dermatitis, pressure urticaria and exacerbation of pre‐existing skin diseases, including seborrheic dermatitis and acne. 1 , 2 We report a preliminary data of HCW who experienced facial dermatoses due to the use of PPE.
From 24 March 2020 to 16 April 2020, we came across with 43 patients comprising physicians, nurses and paramedical staff who involved (directly/indirectly) in managing patients of COVID‐19. We used telemedicine to consult these patients. Their history, clinical findings including onset, duration, location, clinical features and other associated symptoms of dermatoses and type of PPE used were recorded. However, patch could not be performed. Final diagnosis was based on history, clinical findings and pattern of dermatoses and symptoms.
The most commonly noted dermatoses were irritant contact dermatitis (ICD; 39.5%) followed by friction dermatitis (25.5%). Goggles were the most common culprit agent among all PPE causing any one of the dermatoses (51.92%), followed by N95 masks (30.77%) and face shields (17.31%). Nasal bridge (63%) was the commonest anatomical site affected due to dermatoses followed by cheeks and chin (26%). However, there was a considerable overlap of different dermatoses with affliction of multiple sites. The most common symptom experienced by patients was pruritus (67.44%), while erythema (53.49%) was the most common sign observed. Interestingly, we observed two distinct dermatoses, i.e. whole face erythema (suffusion; 21%) attributed to doffing after a long shift and lip lick dermatitis due to constant licking of lips, because of feeling of intense thirst due to restricted fluid intake after donning PPE. The duration of wearing the goggles and mask, excessive sweating and ill‐fitting masks, all were associated with increased sensation of irritation. Most of these dermatoses responded well to topical moisturizer, calamine lotion and oral antihistamines. Overall, 21% patients suffered from work absenteeism due to one of the dermatoses (Table 1).
Table 1.
Variables | Number (n) | Percentage (%) |
---|---|---|
Number of patients | 43 | – |
Mean age | 32.78 ± 14.51 | – |
Sex (Male: Female) | 1.39 | – |
Average duration PPE worn per day (hours): | 8.76 ± 2.31 | – |
Average time after which rotation/doffing done (hours): | 4.08 ± 1.01 | – |
Healthcare role: | ||
i. Doctors | 31 | 72.09 |
ii. Nurses | 9 | 20.93 |
iii. Miscellaneous like ward assistants/cleaners/transport teams | 3 | 6.98 |
Type of dermatoses: | ||
i. Irritant contact dermatitis | 17 | 39.53 |
ii. Allergic dermatitis | 03 | 6.98 |
iii. Pressure/friction marks/rhagades | 11 | 25.58 |
iv. Sweat dermatitis | 07 | 16.28 |
v. Facial acne | 05 | 11.63 |
vi. Lip lick dermatitis | 04 | 09.30 |
Site: | ||
i. Forehead | 09 | 20.93 |
ii. Eyelids/canthus (goggle dermatitis) | 12 | 27.91 |
iii. Nasal bridge (goggle and mask dermatitis/pressure dermatosis) | 27 | 62.79 |
iv. Temple (Visor/mask straps) | 09 | 20.93 |
v. Medial concha of ear (N95 respirator straps) | 07 | 16.28 |
vi. Cheeks and chin | 11 | 25.58 |
vii. Lips/angle of mouth | 04 | 09.30 |
Symptoms: | ||
i. Itching | 29 | 67.44 |
ii. Rash/redness | 21 | 48.84 |
iii. Burning | 11 | 25.58 |
iv. Smarting | 08 | 18.60 |
v. Skin tightness/dryness | 16 | 37.21 |
Signs: | ||
i. Erythema | 23 | 53.49 |
ii. Vesicles | 09 | 20.93 |
iii. Scaling | 19 | 44.19 |
iv. Urticaria | 02 | 04.65 |
v. Papules | 07 | 16.28 |
vi. Pustules | 04 | 09.30 |
vii. Pressure indentations and bruising | 20 | 46.51 |
viii. Excessive lacrimation | 08 | 18.60 |
ix. Rhinorrhoea | 06 | 13.95 |
x. Skin discontinuity (Erosions/fissuring/excoriation) | 31 | 72.09 |
Systemic features: | ||
i. Nausea | 05 | 11.63 |
ii. Headaches | 27 | 62.79 |
iii. Sneezing | 04 | 09.30 |
iv. Feeling of intense heat | 37 | 86.05 |
v. Claustrophobia/agitation with PPE suit | 31 | 72.09 |
vi. Facial rubeosis/suffusion | 09 | 20.93 |
Allergic predisposition | 07 | 16.28 |
Treatment given: | ||
i. Spontaneous resolution with frequent breaks alone | 08 | 18.60 |
ii. Topical calamine with aloe vera extracts | 10 | 23.26 |
iii. Topical tacrolimus | 09 | 20.93 |
iv. Topical low to mid potency steroids | 04 | 09.30 |
v. Oat colloidal meal based moisturizer | 24 | 55.81 |
vi. Petroleum jelly | 04 | 09.30 |
vii. Systemic antihistamines | 15 | 34.88 |
Patients requiring rescue steroids | 04 | 09.30 |
Work absenteeism | 09 | 20.93 |
Personal protective equipment‐induced dermatoses occur mainly due to the occlusion and hyper‐hydration effect of PPE and friction leading breach in the epidermal integrity. 1 Recently, in China, authors noted a very high prevalence, i.e. 97% of skin damages in first‐line HCW fighting COVID‐19. 3 Yin Z in his study found N‐95 mask‐induced pressure sore on the nasal bridge in HCW managing COVID‐19 patients. 4 Skin barrier may create a portal of entry for COVID‐19, as angiotensin‐converting enzyme 2, the cell receptor for Severe acute respiratory distress‐related Coronavirus‐2 (SARS‐CoV‐2), is abundantly present in blood vessels of the skin and the basal layer of the epidermis. 5 As cases of COVID‐19 are on rise with exponential phase, we fear that the dermatoses‐induced skin breach and irritation, and frequent touching of face due to latter, may increase the exposure and entry of SARS‐CoV‐2 infection in the healthcare workers.
Air‐conditioning, proper fitting masks, use of better material (latex straps to be avoided) in the goggles and frequent rotation and regular breaks with removal of the mask and wiping of skin to remove sweat, may help in alleviation of dermatoses in HCW. Adequate hydration is useful to avoid dehydration‐induced dermatoses and dry skin. 6 Moisturizers or emollients are needed to restore the integrity of skin barrier and should be applied at least 30 min before wearing mask, to prevent the damage to mask. Staff is advised not to smoke if they have applied emollient containing white soft paraffin, as it is flammable. 6 Low potency topical steroid or tacrolimus is required in some cases if above measures fail. 7
References
- 1. Darlenski R, Tsankov N. Covid‐19 pandemic and the skin ‐ What should dermatologists know? Clin Dermatol 2020. 10.1016/j.clindermatol.2020.03.012. [published online ahead of print, 2020 Apr 18]. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Gheisari M, Araghi F, Moravvej H, Tabary M, Dadkhahfar S. Skin reactions to non‐glove personal protective equipment: an emerging issue in the COVID‐19 Pandemic [published online ahead of print, 2020 Apr 18]. J Eur Acad Dermatol Venereol 2020. 10.1111/jdv.16492 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Lan J, Song Z, Miao X et al. Skin damage among healthcare workers managing coronavirus disease‐2019. J Am Acad Dermatol 2020; 82: 1215–1216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Yin Z. Covid‐19: Countermeasure for N95 mask‐induced pressure sore [published online ahead of print, 2020 Apr 18]. J Eur Acad Dermatol Venereol 2020. 10.1111/jdv.16490 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004; 203: 631–637. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. https://www.england.nhs.uk/coronavirus/wp‐content/uploads/sites/52/2020/04/C0129_Preventing‐skin‐damage‐under‐PPE_9‐April.pdf (last accessed: 17 April 2020).
- 7. https://www.bad.org.uk/shared/get‐file.ashx?itemtype=document&id=6675 (last accessed: 17 April 2020).